issuers including disclosure of assessment factors; (3) the investment limit is capped at no more than 100,000 baht for each retail investor, equity and debentures combined, up from no more than 50,000
securities and derivative contracts that the clients wish to trade with no limit, in order for investors to have options and opportunity for investment in products that they wish to invest in, and the stop
Gross (loss) profit 71.1 3.9 (12.1) (4.0) 83.2 687.6 Selling expenses (37.9) (2.1) (9.5) (3.1) 28.4 298.9 Administrative expenses (62.2) (3.4) (9.7) (3.2) 52.5 541.2 Finance costs 0.3 0.0 - - 0.3 100.0
146.47% Profit before income tax expenses 42.67 111.79 (69.11) -61.83% Income tax expenses (revenues) 1.27 0.58 0.69 119.50% Profit for the year 41.40 111.21 (69.81) -62.77% Unrealised gain on revaluation
follows; Performance Highlights for Q1/2019 Net Profit attributed to Equity Shareholders was 144.5 million Baht, increased 24.5% from the same period last year and increase 9.5% from Q4/2018. This
Company’s net profit decreased by 67.76% or equal to Baht 13.91 million as compared to the same quarter of 2018 which was recorded at Baht 43.14 million. For 1H19, the Company recorded the net profit of Baht
99.93% Selling expenses 12.23 4.58 7.65 167.03% Administrative expenses 19.75 14.31 5.44 38.02% Finance cost 0.53 0.89 (0.36) (40.45%) Profit before income tax expenses 113.42 55.02 58.40 106.14% Income
follows: Statements of Comprehensive Income for the 1st Quarter Ended March 31, 2020 Revenue from Hospital Operations Operation : Consolidated Profit & Loss Statement 1Q 1Q % Unit : THB million 2020 2019
% which mainly decreased from the revenue from services. The total cost was reported at THB 139.0 million, decreased by THB 54.1 million or 28.0%. As a result, the gross profit margin for this quarter was
or 11.7%. The gross profit for the year 2019 was decreased by THB 25.1 million or 23.0% and gross profit margin to revenues was at 11.1%. The Group reported total net profit for the year 2019 at THB